CD4+CD25+CD127low/− regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression
- 1 April 2009
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 131 (1), 109-118
- https://doi.org/10.1016/j.clim.2008.11.010
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Gastric cancer cells exploit CD4+ cell‐derived CCL5 for their growth and prevention of CD8+ cell‐involved tumor eliminationInternational Journal of Cancer, 2008
- FOXP3+ Regulatory T Cells Affect the Development and Progression of HepatocarcinogenesisClinical Cancer Research, 2007
- Decreased NKG2D Expression on CD8+ T Cell Is Involved in Immune Evasion in Patients with Gastric CancerClinical Cancer Research, 2007
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsThe Journal of Experimental Medicine, 2006
- To the editor - Eur. J. Immunol. 1/2006European Journal of Immunology, 2005
- TGF-β regulatesin vivoexpansion of Foxp3-expressing CD4+CD25+regulatory T cells responsible for protection against diabetesProceedings of the National Academy of Sciences, 2004
- Gastric cancer epidemiology and risk factorsJournal of Clinical Epidemiology, 2003
- CD4+CD25high Regulatory Cells in Human Peripheral BloodPublished by The American Association of Immunologists ,2001